NAVB--time to load. - 未名空间MITBBS历史存档

NAVB--time to load.# Stock

g*e2013-01-20 08:01

1 楼

Current price: $2.97
Lymphoseek FDA decision target date: April 30th
NAVB got a CRL due to only manufacturing issues. These problems were fixed
before EU submission. So FDA approval could be earlier before PDUFA date.
The company is very optimistic on the approval. Per financial update PR on
12/11/2012: ".... prepare for Lymphoseek commercialization, as we
confidently anticipate US approval.”
Technically, it is in uptrend and tested $3 resistance level many times(
warrant exercise explained in above PR gave the reason why keep it in low
price). Now it is about time to break through and move much higher.
Short term target before PDUFA: $4.5

M*y2013-01-20 08:01

2 楼

thanks.
put it on my watch list.

M*82013-01-20 08:01

3 楼

NAVB: BEARISH IF >~ 3.1987
http://www.mitbbs.com/article_t/Stock/34573131.html

【在 g****e 的大作中提到】

: Current price: $2.97
: Lymphoseek FDA decision target date: April 30th
: NAVB got a CRL due to only manufacturing issues. These problems were fixed
: before EU submission. So FDA approval could be earlier before PDUFA date.
: The company is very optimistic on the approval. Per financial update PR on
: 12/11/2012: ".... prepare for Lymphoseek commercialization, as we
: confidently anticipate US approval.”
: Technically, it is in uptrend and tested $3 resistance level many times(
: warrant exercise explained in above PR gave the reason why keep it in low
: price). Now it is about time to break through and move much higher.

s*92013-01-20 08:01

4 楼

stared running to 4.5?

【在 g****e 的大作中提到】

: Current price: $2.97
: Lymphoseek FDA decision target date: April 30th
: NAVB got a CRL due to only manufacturing issues. These problems were fixed
: before EU submission. So FDA approval could be earlier before PDUFA date.
: The company is very optimistic on the approval. Per financial update PR on
: 12/11/2012: ".... prepare for Lymphoseek commercialization, as we
: confidently anticipate US approval.”
: Technically, it is in uptrend and tested $3 resistance level many times(
: warrant exercise explained in above PR gave the reason why keep it in low
: price). Now it is about time to break through and move much higher.

g*e2013-01-20 08:01

5 楼

Hold some more time, but I will take profit if over 20% gain(for any stocks)
.

s*92013-01-20 08:01

6 楼

So strong.
3.5 very soon!
Good call Geroge. Thanks for sharing.

g*e2013-01-20 08:01

7 楼

It went 3.4 since lat call. Now it went back $3 the buying territory again.
Watch it and don't missing this buying opportunity. Good luck!!

g*e2013-01-20 08:01

8 楼

Current price: $2.97
Lymphoseek FDA decision target date: April 30th
NAVB got a CRL due to only manufacturing issues. These problems were fixed
before EU submission. So FDA approval could be earlier before PDUFA date.
The company is very optimistic on the approval. Per financial update PR on
12/11/2012: ".... prepare for Lymphoseek commercialization, as we
confidently anticipate US approval.”
Technically, it is in uptrend and tested $3 resistance level many times(
warrant exercise explained in above PR gave the reason why keep it in low
price). Now it is about time to break through and move much higher.
Short term target before PDUFA: $4.5

M*y2013-01-20 08:01

9 楼

thanks.
put it on my watch list.

M*82013-01-20 08:01

10 楼

NAVB: BEARISH IF >~ 3.1987
http://www.mitbbs.com/article_t/Stock/34573131.html

【在 g****e 的大作中提到】

: Current price: $2.97
: Lymphoseek FDA decision target date: April 30th
: NAVB got a CRL due to only manufacturing issues. These problems were fixed
: before EU submission. So FDA approval could be earlier before PDUFA date.
: The company is very optimistic on the approval. Per financial update PR on
: 12/11/2012: ".... prepare for Lymphoseek commercialization, as we
: confidently anticipate US approval.”
: Technically, it is in uptrend and tested $3 resistance level many times(
: warrant exercise explained in above PR gave the reason why keep it in low
: price). Now it is about time to break through and move much higher.

s*92013-01-20 08:01

11 楼

stared running to 4.5?

【在 g****e 的大作中提到】

: Current price: $2.97
: Lymphoseek FDA decision target date: April 30th
: NAVB got a CRL due to only manufacturing issues. These problems were fixed
: before EU submission. So FDA approval could be earlier before PDUFA date.
: The company is very optimistic on the approval. Per financial update PR on
: 12/11/2012: ".... prepare for Lymphoseek commercialization, as we
: confidently anticipate US approval.”
: Technically, it is in uptrend and tested $3 resistance level many times(
: warrant exercise explained in above PR gave the reason why keep it in low
: price). Now it is about time to break through and move much higher.

g*e2013-01-20 08:01

12 楼

Hold some more time, but I will take profit if over 20% gain(for any stocks)
.

s*92013-01-20 08:01

13 楼

So strong.
3.5 very soon!
Good call Geroge. Thanks for sharing.

g*e2013-01-20 08:01

14 楼

It went 3.4 since lat call. Now it went back $3 the buying territory again.
Watch it and don't missing this buying opportunity. Good luck!!

m*c2013-01-20 08:01

15 楼

approve了还跌这么狠？

.

【在 g****e 的大作中提到】

: It went 3.4 since lat call. Now it went back $3 the buying territory again.
: Watch it and don't missing this buying opportunity. Good luck!!